AT03-65
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AT03-65, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors [Phase 1]